Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MY7F
|
|||
| Former ID |
DNCL001842
|
|||
| Drug Name |
BB3
|
|||
| Synonyms |
3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethylbenzofuran-6-sulfonamide; 765317-71-3; 3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID DIMETHYLAMIDE; BB3; 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethyl-1-benzofuran-6-sulfonamide; SCHEMBL4320310; AC1L9M79; 1t48; ZINC14881085; AKOS025404898; DB04142; AK174884; N,N-Dimethyl-2-ethyl-3-(3,5-dibromo-4-hydroxybenzoyl)benzofuran-6-sulfonamide; 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N,N-dimethylbenzofuran -6-sulfonamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cerebrovascular ischaemia [ICD-11: 8B1Z; ICD-10: I67.8] | Phase 3 | [1] | |
| Congestive heart failure [ICD-11: BD10; ICD-10: I50.0] | Phase 3 | [1] | ||
| Graft-versus-host disease [ICD-11: 4B24] | Phase 3 | [2] | ||
| Company |
Angion Therapeutics
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17Br2NO5S
|
|||
| Canonical SMILES |
CCC1=C(C2=C(O1)C=C(C=C2)S(=O)(=O)N(C)C)C(=O)C3=CC(=C(C(=C3)Br)O)Br
|
|||
| InChI |
1S/C19H17Br2NO5S/c1-4-15-17(18(23)10-7-13(20)19(24)14(21)8-10)12-6-5-11(9-16(12)27-15)28(25,26)22(2)3/h5-9,24H,4H2,1-3H3
|
|||
| InChIKey |
FEYGJZKVMASWJB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Angion Therapeutics. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.